PFIZER
Back to Cashflow Statement
|
PFIZER Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-235 Cr | ₹-346 Cr | ₹-181 Cr | ₹-1,571 Cr | ₹-164 Cr |
What is the latest Cash Flow from Financing Activities ratio of PFIZER ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-235 Cr |
Mar2023 | ₹-346 Cr |
Mar2022 | ₹-181 Cr |
Mar2021 | ₹-1,571 Cr |
Mar2020 | ₹-164 Cr |
How is Cash Flow from Financing Activities of PFIZER Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-235 Cr | Negative | |
Mar2023 | ₹-346 Cr | Negative | |
Mar2022 | ₹-181 Cr | Negative | |
Mar2021 | ₹-1,571 Cr | Negative | |
Mar2020 | ₹-164 Cr | - |
Compare Cash Flow from Financing Activities of peers of PFIZER
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PFIZER | ₹24,223.3 Cr | 1.5% | 0.4% | 28.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,321.0 Cr | -3.5% | -8.8% | 46% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,049.0 Cr | -0.8% | 2.5% | 62.8% | Stock Analytics | |
CIPLA | ₹120,564.0 Cr | 0.4% | -0.7% | 27.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,512.9 Cr | -1.8% | -9.1% | 6.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,426.2 Cr | -0% | -5.8% | 50.7% | Stock Analytics |
PFIZER Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PFIZER | 1.5% |
0.4% |
28.6% |
SENSEX | 2.5% |
-0.5% |
19.7% |
You may also like the below Video Courses